Menu
Healthcare Copywriting & Lead Generation
9 days from first send to first call. 71% of the emails got opened, in the first week of a single outbound sequence.
I'm a pharmacist finishing an MSc in Pharmacoeconomics. I write copy and build outbound systems for healthcare and health-tech companies, currently running outbound and recruitment copy for a patient recruitment platform in LA, working with Sponsors, CROs, and research sites across the US.
Why does a PRO or site need an outbound engine? As of August 2026, email marketing is still one of the most effective marketing channels, with an ROI of roughly 3,600–4,200%, that's $36 to $42 in revenue for every $1 spent.
In B2B outbound specifically, the role of this channel is even more evident. A well-run email engine can secure introductory calls for the business, serving as the starting point for a major contract.
Source: industry-wide email marketing ROI benchmarks (Litmus, DMA, Omnisend), 2026. Figure reflects email marketing broadly, not cold B2B outreach specifically.9 days from launch to first call, for a PRO sponsor in Los Angeles
"Thanks for getting back to our team. Emily Johnson shared your contact information with me, and I'm helping with the recruitment efforts for our Phase 2 ADP Vista study. We'd love to learn more about WeHealth's services and capabilities and discuss our recruitment needs... Looking forward to connecting!"
Based on open-rate and click-through data since, this pilot is projected to generate at least two or three additional introductory calls, as the metrics indicate the engine is performing effectively. All collected data is analyzed in real time to optimize the pilot. For instance, leads who open an email multiple times without replying are approached with a different strategy than leads who don't open it at all.
Healthcare copy often gets written like any other niche, and healthcare lead gen often treats every buyer the same way. Both approaches fail with a skeptical, well-informed audience.
Knowing what a Clinical Ops buyer needs versus a Marketing Director, or when copy needs to be precise rather than just convert, is daily work for me.
70% of the work is research: understanding the category, the compliance line, and the person reading it, before I write a single line. The other 30% is putting that into words.
70/30 also happens to be a real insulin mix, NPH and regular. I like the coincidence.
See how the 70/30 Rx Method applies to your own teamHealthcare copy usually overclaims or plays it too safe, because the writer doesn't know where the compliance line sits. A supplement claim, an Rx ad, and a trial recruitment email follow different rules.
Every project starts with the category, what can legally be claimed, and who's reading it. About 70% of the work is research, before I write a single line.
Step 01, in detail
Step 02, in detail
Most B2B outbound personalizes down to a name and a company, rarely further. Reaching the trial, the drug, or the patient behind it is what makes a sponsor feel like the outreach was meant for them.
Every campaign starts with a real trigger: an active trial, a funding round, a new hire. Then research the buyer underneath it, build a verified list, and write to that trigger specifically.
Step 01, in detail
Step 02, in detail
Start without a retainer, and if a compliance reviewer flags something I should have caught, I'll fix it at no charge.
Self-initiated case study, not affiliated with Antidote or Roche.
Antidote is past the "we have AI matching" pitch, since every vendor says that now. The real differentiation is in the mechanism behind the match.
I built the full funnel around one idea: the validation layer protects a trial's cohort. Cold email, LinkedIn, patient ads, the landing page, and nurture emails carry that same mechanism, in different voices for different readers.
